Drugs for Neglected Diseases initiative donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2025. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Basic donee information
Donee donation statistics
Donee donation amounts by donor and year
Donee document list
Donee donation list

Basic donee information

Item	Value
Country
Facebook page	dndi.org
Website	https://www.dndi.org/
Twitter username	DNDi
Wikipedia page	https://en.wikipedia.org/wiki/Drugs_for_Neglected_Diseases_Initiative
Instagram username	drugsforneglecteddiseases

Donee donation statistics

Cause area	Count	Median	Mean	Minimum	10th percentile	20th percentile	30th percentile	40th percentile	50th percentile	60th percentile	70th percentile	80th percentile	90th percentile	Maximum
Overall	18	1,868,635	7,345,316	-1,522,143	0	53,058	1,000,000	1,713,553	1,868,635	2,352,649	4,802,610	9,000,000	25,729,285	59,867,585
Global health	15	2,352,649	8,572,029	-1,522,143	0	0	1,000,000	1,500,000	2,352,649	4,398,239	5,787,659	9,000,000	25,729,285	59,867,585
FIXME	3	1,713,553	1,211,749	53,058	53,058	53,058	53,058	1,713,553	1,713,553	1,713,553	1,868,635	1,868,635	1,868,635	1,868,635

Donation amounts by donor and year for donee Drugs for Neglected Diseases initiative

Donor	Total	2017	2015	2014	2013	2011	2010	2009	2007
Bill and Melinda Gates Foundation (filter this donee)	128,580,434.00	4,802,610.00	-1,335,450.00	63,743,681.00	2,352,649.00	16,787,659.00	1,500,000.00	15,000,000.00	25,729,285.00
Wellcome Trust (filter this donee)	3,635,246.00	0.00	0.00	0.00	53,058.00	3,582,188.00	0.00	0.00	0.00
Total	132,215,680.00	4,802,610.00	-1,335,450.00	63,743,681.00	2,405,707.00	20,369,847.00	1,500,000.00	15,000,000.00	25,729,285.00

Full list of documents in reverse chronological order (1 documents)

Title (URL linked)	Publication date	Author	Publisher	Affected donors	Affected donees	Affected influencers	Document scope	Cause area	Notes
Sindy li: current view, Against Malaria Foundation	2017-02-19	Sindy Li	Oxford Prioritisation Project	Oxford Prioritisation Project	Against Malaria Foundation Schistosomiasis Control Initiative Drugs for Neglected Diseases Initiative		Evaluator review of donee	Global health	Sindy Li provides her best guess as to the best opportunity for the Oxford Prioritisation Project, saying it is the Against Malaria Foundation. Her analysis relies on the GiveWell cost-effectiveness estimates. She identifies mental health as another area (citing https://oxpr.io/blog/2017/2/28/lovisa-tengberg-current-view-strongminds by Lovisa Tengberg and https://oxpr.io/blog/2017/2/28/konstantin-sietzy-current-view-strongminds by Konstantin Sietzy) that she might look into more

Full list of donations in reverse chronological order (18 donations)

Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations

Donor	Amount (current USD)	Amount rank (out of 18)	Donation date	Cause area	URL	Influencer	Notes
Bill and Melinda Gates Foundation	4,802,610.00	6	2017-11-21	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to develop much needed new treatments for filarial diseases (onchocerciasis and lymphatic filariasis), human African trypanosomiasis and visceral leishmaniasis that are safe, effective, easy-to-use (oral) and affordable..; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation	540,152.00	14	2016-05-09	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to develop much needed new treatments for filarial diseases (onchocerciasis and lymphatic filariasis), human African trypanosomiasis and visceral leishmaniasis that are safe, effective, easy-to-use (oral) and affordable..; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation	-540,152.00	16	2016-05-09	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to support the development of flubendazole as a macrofilaricidal drug candidate for treatment of onchocerciasis loa loa co-infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation	-1,335,450.00	17	2015-11-11	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to establish and implement new treatment modalities as successful tools to control and support the elimination of Visceral Leishmaniasis in the most endemic regions of South Asia; Aid type: Project-type interventions. Affected regions: South & Central Asia.
Bill and Melinda Gates Foundation	59,867,585.00	1	2014-10-24	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to develop much needed new treatments for filarial diseases (onchocerciasis and lymphatic filariasis), human African trypanosomiasis and visceral leishmaniasis that are safe, effective, easy-to-use (oral) and affordable..; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation	4,398,239.00	7	2014-07-10	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	for clinical development of Oral Fexinidazole for stage 2 Human African Trypanosomiasis; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation	1,000,000.00	13	2014-05-06	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	To foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation	-1,522,143.00	18	2014-04-29	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to support the development of flubendazole as a macrofilaricidal drug candidate for treatment of onchocerciasis loa loa co-infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Wellcome Trust	53,058.00	15	2013-09-16	FIXME	https://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx	--	USD 3 Million Awarded to Find Biomarkers for Potential Test of Cure for Chagas Disease. Affected regions: International; affected countries: Switzerland.
Bill and Melinda Gates Foundation	2,352,649.00	8	2013-06-26	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to identify new drug candidates for helminths and kinetoplastid diseases. NTD Screening. Investment start date: 11/2/2011 to end date: 3/31/2015. Grantee name: Drugs for Neglected Diseases initiative; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation	2,000,000.00	9	2011-11-02	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to identify new drug candidates for helminths and kinetoplastid diseases. NTD Screening. Investment start date: 11/2/2011 to end date: 3/31/2015. Grantee name: Drugs for Neglected Diseases initiative; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Wellcome Trust	1,868,635.00	10	2011-07-13	FIXME	https://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx	--	USD 3 Million Awarded to Find Biomarkers for Potential Test of Cure for Chagas Disease. Affected regions: International; affected countries: Switzerland.
Bill and Melinda Gates Foundation	9,000,000.00	4	2011-06-23	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to establish and implement new treatment modalities as successful tools to control and support the elimination of Visceral Leishmaniasis in the most endemic regions of South Asia; Aid type: Project-type interventions. Affected regions: South & Central Asia.
Bill and Melinda Gates Foundation	5,787,659.00	5	2011-04-15	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to support the development of flubendazole as a macrofilaricidal drug candidate for treatment of onchocerciasis loa loa co-infections; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Wellcome Trust	1,713,553.00	11	2011-01-19	FIXME	https://wellcome.ac.uk/sites/default/files/wellcome-grants-awarded-2000-2016.xlsx	--	Development of E1224 for the treatment of Chagas Disease" to evaluate a promising alternative drug candidate for Chagas disease. Affected regions: International; affected countries: Switzerland.
Bill and Melinda Gates Foundation	1,500,000.00	12	2010-06-25	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to develop new drug candidates for human African trypanosomiasis and visceral leishmaniasis through the pre-clinical stage and ready for an Investigational New Drug filing, and the completion of phase I clinical studies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation	15,000,000.00	3	2009-11-10	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	for clinical development of Oral Fexinidazole for stage 2 Human African Trypanosomiasis; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation	25,729,285.00	2	2007-11-12	Global health/infectious disease control	https://iatiregistry.org/publisher/bmgf	--	to develop new drug candidates for human African trypanosomiasis and visceral leishmaniasis through the pre-clinical stage and ready for an Investigational New Drug filing, and the completion of phase I clinical studies; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.